Tiny structures made out of genetic code are capable of releasing payloads of molecules directly to specific cell "addresses" in the body.
Study participants are swallowing pills containing gene-modified E. coli bacteria designed to absorb excess ammonia in the body.
Dietary supplement companies are moving away from big box retail, focusing on subscriptions and extreme personalization.
Healthcare is changing around the world. The very definition of medicine is now up for debate. Across digital health, biotechnology, and the medical device sector, startups are finally bringing medicine into the 21st century. In this report we take a look at cutting edge developments in healthcare, and the startups behind them that are just beginning to impact the world.
Blocking ApoE4 in the brain may prevent the nerve cell death and inflammation that cause brain damage in Alzheimer’s patients.
New research uses an algorithm to crunch existing administrative data to predict if a patient will be diagnosed.
A team of MIT scientists have found a way to use sound waves to separate the nanoparticles in blood and analyze them as biomarkers of disease.
Scientists screened a library of 100 million antibodies to find several that offer an easier way to reprogram adult cells into stem cells.
We dug into the Chinese startup’s private market footprint and its ambitious plan to digitize your entire body.
Early-stage blockchain startups are tackling major issues in healthcare from medical record interoperability to pharmaceutical supply chain management.